{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:10:51Z","timestamp":1697440251990},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T00:00:00Z","timestamp":1288310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:sec><jats:label \/><jats:p> <jats:italic>Aliment Pharmacol Ther<\/jats:italic> 2011; <jats:bold>33:<\/jats:bold> 41\u201349<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Response to proton pump inhibitor (PPI) treatment in dyspepsia is unpredictable.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To identify symptoms associated with response to esomeprazole in order to target patients for empirical treatment.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Eight hundred and five uninvestigated, primary care patients with upper GI symptoms that were considered to be acid\u2010related were randomised to 2\u2003weeks\u2019 treatment with esomeprazole 40\u2003mg or placebo. The study population was divided into a model sample (<jats:italic>N\u2003=<\/jats:italic>\u2003484) and a validation sample (<jats:italic>N\u2003=<\/jats:italic>\u2003321). We developed a therapeutic index to predict PPI response from the model sample and tested this in the validation sample.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Response to PPI was found in 68% of patients (44% in placebo arm). Bothersome heartburn and early satiety were associated with increased likelihood of PPI response, whereas dull abdominal pain, pain relieved by bowel movements and nausea in women were associated with a decreased likelihood of PPI response. Patients in the validation sample could be classified as having a \u2018very high\u2019 (<jats:italic>n\u2003=<\/jats:italic>\u200355), \u2018high\u2019 (<jats:italic>n\u2003=<\/jats:italic>\u2003123), \u2018medium\u2019 (<jats:italic>n\u2003=<\/jats:italic>\u200378) or \u2018low\u2019 (<jats:italic>n\u2003=<\/jats:italic>\u200365) probability of PPI response. The therapeutic gains over placebo were 55%, 31%, 20% and 22%, respectively.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> In patients with uninvestigated dyspepsia, PPI responders can be reliably identified by a simple pocket chart using symptoms and patient characteristics (ClinicalTrials.gov NCT00318968).<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2010.04501.x","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T12:50:57Z","timestamp":1288356657000},"page":"41-49","source":"Crossref","is-referenced-by-count":7,"title":["Randomised clinical trial: identification of responders to short\u2010term treatment with esomeprazole for dyspepsia in primary care \u2013 a randomised, placebo\u2010controlled study"],"prefix":"10.1111","volume":"33","author":[{"given":"V.","family":"Meineche\u2010Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bytzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,10,29]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.09.020"},{"issue":"12","key":"e_1_2_6_3_2","first-page":"S3","article-title":"An evidence\u2010based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori","volume":"162","author":"Veldhuyzen van Zanten S","year":"2000","journal-title":"Can Med Assoc J"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520410003452"},{"key":"e_1_2_6_5_2","first-page":"3777","article-title":"General practitioners\u2019 handling of patients with dyspepsia","volume":"159","author":"Folkersen BH","year":"1997","journal-title":"Ugeskr Laeger"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310000528"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/10.4.387"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30089.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02243.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02306.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/gut.45.2008.ii37","article-title":"Functional gastroduodenal disorders","volume":"45","author":"Talley NJ","year":"1999","journal-title":"Gut"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365529850172340"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/13814789709160347"},{"key":"e_1_2_6_14_2","volume-title":"Statistical Methods in Medical Research","author":"Armitage P","year":"1994"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.03.058"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.01.004"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03102.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1998.275.5.G1209"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40280.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03409.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01651.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03410.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.034298"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02983.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2010.04501.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2010.04501.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:52:28Z","timestamp":1697381548000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2010.04501.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,29]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1111\/j.1365-2036.2010.04501.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04501.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,29]]}}}